Related Experiment Video

Updated: May 16, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Apoptosis induction, cell cycle arrest and in vitro anticancer activity of gonothalamin in a cancer cell lines

Aied M Alabsi1, Rola Ali, Abdul Manaf Ali

  • 1Department of Biotechnology, Universiti Sultan Zainal Abidin (UniSZA), Kuala Terengganu, Malaysia. aied_absi@yahoo.com

Asian Pacific Journal of Cancer Prevention : APJCP
|December 19, 2012
PubMed

Insights

Goniothalamin, a natural compound, demonstrates significant cytotoxicity against cervical, breast, and colon cancer cells. This plant-derived compound effectively induces apoptosis, a programmed cell death, in cancer cells, offering a potential alternative cancer treatment.

Area of Science:

  • Natural product chemistry
  • Cancer biology
  • Pharmacology

Background:

  • Cancer poses a significant global health challenge with current treatments causing adverse effects.
  • Natural compounds derived from plants are being explored as potential anti-cancer agents.
  • Goniothalamin (GTN) is a styryl-lactone isolated from Goniothalamus macrophyllus.

Purpose of the Study:

  • To investigate the cytotoxic properties of goniothalamin against various cancer cell lines.
  • To determine the mechanism of cell death induced by goniothalamin in cervical cancer cells.
  • To evaluate goniothalamin as a potential anti-cancer therapeutic.

Main Methods:

  • MTT assay was used to assess cytotoxicity against HeLa (cervical), MCF-7 (breast), and HT29 (colon) cancer cells, and 3T3 (normal mouse fibroblast) cells.
  • Fluorescence microscopy and flow cytometry were employed to analyze apoptosis and cell cycle arrest.
  • Annexin V/PI double staining was utilized for early detection of apoptosis.

Main Results:

  • Goniothalamin exhibited cytotoxic effects on cervical, breast, and colon cancer cell lines.
  • GTN induced apoptosis in HeLa cells in a time-dependent manner.
  • HeLa cells treated with GTN showed S-phase arrest, and early apoptosis was confirmed via annexin V/PI staining.

Conclusions:

  • Goniothalamin displays promising cytotoxic activity against multiple cancer cell lines.
  • Apoptosis is the primary mechanism of cell death induced by goniothalamin in HeLa cells.
  • Goniothalamin represents a potential candidate for developing novel cancer therapies.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Cell Cycle-specific Measurement of γH2AX and Apoptosis After Genotoxic Stress by Flow Cytometry08:21

Cell Cycle-specific Measurement of γH2AX and Apoptosis After Genotoxic Stress by Flow Cytometry

Published on: September 1, 2019

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...